EYPT FY 2019 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+587.8% YoY

Gross Profit

$18M86.8% margin

Operating Income

-$48M-235.0% margin

Net Income

-$57M-278.9% margin

EPS (Diluted)

$-6.04

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$57M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$73M

Total Liabilities

$65M

Stockholders' Equity

$8M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$3M	+587.8%
Gross Profit	$18M	-$16M	+213.8%
Operating Income	-$48M	-$26M	-82.2%
Net Income	-$57M	-$53M	-6.8%